Macquarie Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.52M | Buy |
61,075
+3,239
| +6% | +$271K | 0.02% | 387 |
|
|
2026
Q1 | $4.63M | Sell |
57,836
-53,432
| -48% | -$4.41M | 0.03% | 363 |
|
|
2025
Q4 | $9.49M | Sell |
111,268
-1,116,898
| -91% | -$91.7M | 0.04% | 299 |
|
|
2025
Q3 | $95.5M | Buy |
1,228,166
+160,478
| +15% | +$12.5M | 0.11% | 241 |
|
|
2025
Q2 | $83.5M | Buy |
1,067,688
+873,042
| +449% | +$65.1M | 0.1% | 283 |
|
|
2025
Q1 | $14.1M | Buy |
194,646
+45,660
| +31% | +$3.27M | 0.02% | 741 |
|
|
2024
Q4 | $9.34M | Sell |
148,986
-3,771
| -2% | -$264K | 0.01% | 820 |
|
|
2024
Q3 | $10.1M | Sell |
152,757
-1,678,559
| -92% | -$122M | 0.01% | 819 |
|
|
2024
Q2 | $169M | Sell |
1,831,316
-35,043
| -2% | -$3.1M | 0.19% | 126 |
|
|
2024
Q1 | $178M | Sell |
1,866,359
-133,921
| -7% | -$11.2M | 0.2% | 119 |
|
|
2023
Q4 | $153M | Sell |
2,000,280
-34,431
| -2% | -$2.4M | 0.18% | 146 |
|
|
2023
Q3 | $141M | Buy |
2,034,711
+328,211
| +19% | +$26.4M | 0.18% | 144 |
|
|
2023
Q2 | $161M | Buy |
1,706,500
+19,440
| +1% | +$1.69M | 0.18% | 141 |
|
|
2023
Q1 | $140M | Sell |
1,687,060
-605,178
| -26% | -$47.6M | 0.17% | 164 |
|
|
2022
Q4 | $171M | Buy |
2,292,238
+208,090
| +10% | +$16M | 0.2% | 118 |
|
|
2022
Q3 | $172M | Buy |
2,084,148
+653,969
| +46% | +$62.9M | 0.21% | 106 |
|
|
2022
Q2 | $136M | Sell |
1,430,179
-136,134
| -9% | -$14.1M | 0.15% | 167 |
|
|
2022
Q1 | $184K | Sell |
1,566,313
-106,921
| -6% | -$12M | 0.14% | 150 |
|
|
2021
Q4 | $217M | Sell |
1,673,234
-37,524
| -2% | -$4.38M | 0.18% | 132 |
|
|
2021
Q3 | $194M | Sell |
1,710,758
-166,487
| -9% | -$19M | 0.17% | 144 |
|
|
2021
Q2 | $194M | Buy |
1,877,245
+257,857
| +16% | +$24.3M | 0.16% | 146 |
|
|
2021
Q1 | $135M | Sell |
1,619,388
-104,912
| -6% | -$8.87M | 0.19% | 115 |
|
|
2020
Q4 | $157M | Buy |
1,724,300
+254,030
| +17% | +$21.1M | 0.23% | 93 |
|
|
2020
Q3 | $117M | Buy |
1,470,270
+1,162,530
| +378% | +$90.7M | 0.2% | 100 |
|
|
2020
Q2 | $21.3M | Sell |
307,740
-9,975
| -3% | -$709K | 0.04% | 448 |
|
|
2020
Q1 | $20M | Sell |
317,715
-23,292
| -7% | -$1.68M | 0.04% | 417 |
|
|
2019
Q4 | $26.5M | Buy |
341,007
+233,565
| +217% | +$18.2M | 0.04% | 436 |
|
|
2019
Q3 | $7.88M | Sell |
107,442
-9,087
| -8% | -$638K | 0.01% | 650 |
|
|
2019
Q2 | $7.18M | Sell |
116,529
-8,235
| -7% | -$498K | 0.01% | 685 |
|
|
2019
Q1 | $7.96M | Sell |
124,764
-48,708
| -28% | -$2.78M | 0.01% | 669 |
|
|
2018
Q4 | $8.86M | Sell |
173,472
-14,610
| -8% | -$739K | 0.02% | 615 |
|
|
2018
Q3 | $10.9M | Buy |
188,082
+28,650
| +18% | +$1.4M | 0.02% | 624 |
|
|
2018
Q2 | $7.74M | Sell |
159,432
-8,907
| -5% | -$416K | 0.01% | 683 |
|
|
2018
Q1 | $7.83M | Sell |
168,339
-41,550
| -20% | -$1.8M | 0.01% | 662 |
|
|
2017
Q4 | $7.77M | Buy |
209,889
+1,872
| +0.9% | +$68.7K | 0.01% | 691 |
|
|
2017
Q3 | $7.58M | Sell |
208,017
-91,383
| -31% | -$3.49M | 0.01% | 670 |
|
|
2017
Q2 | $11.8M | Sell |
299,400
-88,173
| -23% | -$3.22M | 0.02% | 568 |
|
|
2017
Q1 | $12.2M | Sell |
387,573
-60,567
| -14% | -$1.9M | 0.02% | 570 |
|
|
2016
Q4 | $14M | Buy |
448,140
+162,588
| +57% | +$5.27M | 0.03% | 531 |
|
|
2016
Q3 | $11.5M | Sell |
285,552
-147,450
| -34% | -$5.55M | 0.02% | 565 |
|
|
2016
Q2 | $14.4M | Buy |
433,002
+210,102
| +94% | +$7.19M | 0.01% | 638 |
|
|
2016
Q1 | $6.55M | Sell |
222,900
-79,500
| -26% | -$2.19M | 0.01% | 652 |
|
|
2015
Q4 | $7.96M | Buy |
302,400
+24,900
| +9% | +$647K | 0.02% | 598 |
|
|
2015
Q3 | $6.58M | Buy |
277,500
+255,300
| +1,150% | +$6.16M | 0.01% | 649 |
|
|
2015
Q2 | $527K | Hold |
22,200
| – | – | ﹤0.01% | 1289 |
|
|
2015
Q1 | $527K | Hold |
22,200
| – | – | ﹤0.01% | 1255 |
|
|
2014
Q4 | $471K | Hold |
22,200
| – | – | ﹤0.01% | 1278 |
|
|
2014
Q3 | $378K | Hold |
22,200
| – | – | ﹤0.01% | 1307 |
|
|
2014
Q2 | $318K | Sell |
22,200
-1,800
| -8% | -$24.4K | ﹤0.01% | 1375 |
|
|
2014
Q1 | $297K | Hold |
24,000
| – | – | ﹤0.01% | 1359 |
|
|
2013
Q4 | $263K | Buy |
24,000
+8,400
| +54% | +$94.7K | ﹤0.01% | 1363 |
|
|
2013
Q3 | $181K | Sell |
15,600
-109,800
| -88% | -$1.28M | ﹤0.01% | 1427 |
|
|
2013
Q2 | $1.41M | Buy |
+125,400
| New | +$1.48M | ﹤0.01% | 1060 |
|
Other funds holding EW
Macquarie Group's EW Position: Q2 2026 in Review
Macquarie Group increased its Edwards Lifesciences (EW) stake by 5.6% in Q2 2026, buying an estimated $271K and bringing the position to 61,075 shares worth $5.52M. The position accounts for 0.02% of the portfolio, ranked #387.
Macquarie Group first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $217M in Q4 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Macquarie Group held 61,075 shares of Edwards Lifesciences worth $5.52M as of Q2 2026.
- Macquarie Group bought 3,239 Edwards Lifesciences shares in Q2 2026, an estimated $271K.
- Edwards Lifesciences made up 0.02% of Macquarie Group's portfolio in Q2 2026, its #387 holding.
- Macquarie Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Macquarie Group's Edwards Lifesciences position peaked at $217M in Q4 2021.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.